Marc Steven Sabatine, M.D.
This page shows the publications co-authored by Marc Sabatine and Ik-Kyung Jang.
Sabatine MS, Januzzi JL, Snapinn S, Théroux P, Jang IK. A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris. Am J Cardiol. 2001 Sep 01; 88(5):488-92.
Sabatine MS, Tu TM, Jang IK. Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplase. J Thromb Thrombolysis. 2000 Oct; 10(2):189-96.
Sabatine MS, Jang IK. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am J Med. 2000 Aug 15; 109(3):224-37.
Sabatine MS, Jang IK. Antithrombotic therapy in acute coronary syndromes. Acta Cardiol. 1999 Feb; 54(1):3-29.
Januzzi JL, Chae CU, Sabatine MS, Jang IK. Elevation in serum troponin I predicts the benefit of tirofiban. J Thromb Thrombolysis. 2001 May; 11(3):211-5.
Gimelli G, Kalra A, Sabatine MS, Jang IK. Primary versus rescue percutaneous coronary intervention in patients with acute myocardial infarction. Acta Cardiol. 2000 Jun; 55(3):187-92.
Januzzi JL, Sabatine MS, Wan Y, Servoss SJ, DiBattiste PM, Jang Ik, Theroux P. Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy. Am J Cardiol. 2003 Feb 15; 91(4):457-61.
Sheynberg BV, Jang IK, Han RO, Sabatine MS, Brown DF, Dinsmore R. Comparison of two different methods of quantitative coronary angiography in patients with acute coronary syndromes. Catheter Cardiovasc Interv. 2002 Apr; 55(4):442-9.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.